V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004876 | 300003351 | 1.62 | 61.8 | Palliative (P) | 2016-09-24 | 2017-03-20 | CYCLOPHOSPHAMIDE + EPIRUBICIN | 2 | N | 300025961 | BEVACIZUMAB |
| 300004877 | 300003352 | 1.65 | 53.7 | Palliative (P) | 2016-03-29 | 2016-03-29 | GemCarbo Days 1+8 | Y | null | 300025963 | PEMBROLIZUMAB |
| 300004878 | 300003352 | 1.52 | 90 | Palliative (P) | 2013-08-30 | 2013-09-02 | Fluorouracil + Folinic Acid Weekly | null | null | 300025963 | GEMCARBO |
| 300004879 | 300003353 | 1.73 | 61.7 | Curative (C) | 2015-06-30 | 2015-07-22 | CAPECITABINE + IRINOTECAN | 02 | N | 300025968 | GEMCARBO |
| 300004883 | 300003355 | 1.75 | 84.5 | Curative (C) | 2015-11-22 | 2015-12-01 | CARBOPLATIN + GEMCITABINE | 02 | N | 300026001 | IMATINIB |
| 300004884 | 300003355 | 1.79 | 64.5 | Curative (C) | 2016-03-27 | 2016-04-17 | CARBOPLATIN + FLUOROURACIL | 02 | N | 300026001 | CAPECITABINE + GEMCITABINE |
| 300004885 | 300003356 | 1.65 | 63.4 | Palliative (P) | 2016-03-15 | 2016-04-14 | Carboplatin AUC 2 - 5 | N | N | 300026006 | GEMCARBO |
| 300004888 | 300003358 | 1.84 | 71.2 | Palliative (P) | 2016-08-07 | 2016-08-20 | CAPECITABINE + OXALIPLATIN | N | N | 300026013 | CARBOPLATIN + ETOPOSIDE |
| 300004889 | 300003359 | null | 60 | Palliative (P) | 2016-03-30 | 2016-04-20 | Capecitabine (21days) + Carboplatin | N | N | 300026031 | CARBOPLATIN + ETOPOSIDE |
| 300004890 | 300003360 | 1.75 | 75.6 | Palliative (P) | 2016-12-11 | 2016-12-11 | Azacitidine | 02 | N | 300026039 | CARBOPLATIN + RT |
| 300004891 | 300003361 | 1.6 | 45.2 | Curative (C) | 2016-03-28 | 2016-04-23 | GemCarbo Days 1+8 | Y | Y | 300026040 | EOX |
| 300004892 | 300003362 | 1.73 | 43.1 | Curative (C) | 2015-07-29 | 2015-08-24 | Temozolomide + RT | N | Y | 300026042 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004893 | 300003363 | 1.73 | 0 | Neo-adjuvant (N) | 2013-04-29 | 2013-05-06 | ESPAC-4 TRIAL | 02 | N | 300026043 | CARBO + FLUOROURACIL |
| 300004894 | 300006239 | 1.68 | 74 | Curative (C) | 2015-03-29 | 2015-04-03 | ABC-02 TRIAL | 01 | null | 300026044 | CARBOPLATIN + VINORELBINE |
| 300004895 | 300003364 | 1.69 | 70 | null | 2014-02-11 | 2014-02-27 | Carboplatin + Etoposide iv&po | 02 | null | 300026048 | CARBOPLATIN + ETOPOSIDE |
| 300004896 | 300003365 | null | 64.5 | Curative (C) | 2014-10-05 | 2014-10-09 | TCF | N | N | 300026049 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004897 | 300003365 | 1.83 | 68 | Adjuvant (A) | 2017-01-02 | 2017-01-05 | Gemcitabine + Capecitabine | 02 | N | 300026049 | ECX |
| 300004898 | 300003366 | 1.76 | 77 | Adjuvant (A) | 2014-11-28 | 2014-12-13 | Capecitabine + Cisplatin | N | N | 300026081 | CARBOPLATIN + RT |
| 300004899 | 300003367 | null | 53.8 | Curative (C) | 2014-10-28 | 2014-11-03 | FEC 100 | 02 | null | 300026084 | DOCETAXEL |
| 300004901 | 300003369 | null | 60.6 | Curative (C) | 2013-03-01 | 2013-03-14 | Capecitabine + Oxaliplatin 14day | N | N | 300026092 | ESPAC TRIAL |
| 300004902 | 300006241 | 1.74 | 70.3 | Palliative (P) | 2018-02-06 | 2018-02-10 | Gemcitabine + Capecitabine | 02 | N | 300026095 | FLUOROURACIL + MITOMYCIN + RT |
| 300004903 | 300006241 | 1.73 | null | Palliative (P) | 2013-09-04 | 2013-09-16 | Folfirinox | 02 | N | 300026095 | CARBOPLATIN + ETOPOSIDE |
| 300004904 | 300006241 | 1.64 | 92.4 | Palliative (P) | 2017-03-21 | 2017-04-13 | CARBOPLATIN | Y | Y | 300026095 | CARBOPLATIN + CETUXIMAB + FU |
| 300004905 | 300006241 | 1.53 | 58.3 | Neo-adjuvant (N) | 2013-10-23 | 2013-10-29 | Gemcitabine + Capecitabine | 02 | Y | 300026095 | PEMBROLIZUMAB |
| 300004906 | 300003370 | 0 | 68 | Palliative (P) | 2016-02-22 | 2016-02-29 | FLUOROURACIL + MITOMYCIN + RT | N | N | 300026116 | CAPECITABINE + GEMCITABINE |
| 300004907 | 300003371 | 1.5 | 999 | Palliative (P) | 2013-12-29 | 2014-01-04 | Hydroxycarbamide | 2 | N | 300026125 | PEMBROLIZUMAB |
| 300004908 | 300003371 | 1.57 | 88 | null | 2017-06-17 | 2017-06-27 | Gemcitabine + Capecitabine | 02 | null | 300026125 | CISPLATIN + VINORELBINE |
| 300004909 | 300003371 | 1.73 | null | Curative (C) | 2017-11-02 | 2017-11-04 | Cisplatin + Fluorouracil + RT 5day | 02 | null | 300026125 | TCF |
| 300004910 | 300003371 | 1.6 | 108 | Palliative (P) | 2015-03-22 | 2015-03-22 | TRASTUZUMAB | 02 | N | 300026125 | CARBOPLATIN + ETOPOSIDE |
| 300004911 | 300003372 | 1.57 | 114.8 | Neo-adjuvant (N) | 2016-05-28 | 2016-06-13 | ESPAC-4 TRIAL | 02 | N | 300026136 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004912 | 300003372 | 1.8 | 65.6 | Curative (C) | 2015-06-02 | 2015-08-03 | CARBOPLATIN + RT | N | Y | 300026136 | CARBOPLATIN |
| 300004913 | 300003373 | 1.69 | 76 | Palliative (P) | 2014-06-19 | 2014-06-26 | RUXOLITINIB | 02 | N | 300026139 | CARBOPLATIN + LIPOSOMAL DOX |
| 300004914 | 300003374 | null | null | Palliative (P) | 2015-02-24 | 2015-02-27 | GEMCARBO | N | null | 300026146 | FEC |
| 300004915 | 300003375 | null | 73.9 | Palliative (P) | 2015-09-08 | 2015-09-09 | Carboplatin + Cetux + FU (Cycle 1) | 01 | N | 300026151 | LENALIDOMIDE |
| 300004916 | 300006244 | 1.63 | 49.8 | Adjuvant (A) | 2013-08-05 | 2013-08-04 | Carboplatin + Cetux + FU (>Cycle 2) | N | Y | 300026152 | GEFITINIB |
| 300004917 | 300003376 | 1.78 | 89.3 | Neo-adjuvant (N) | 2017-04-18 | 2017-05-03 | CompARE Trial | N | N | 300026161 | BEVACIZUMAB |
| 300004918 | 300003376 | 1.51 | 72.5 | Adjuvant (A) | 2013-07-20 | 2013-10-23 | FLUOROURACIL + MITOMYCIN | N | N | 300026161 | CAPECITABINE + GEMCITABINE |
| 300004919 | 300007517 | 1.48 | 44.6 | Palliative (P) | 2016-03-08 | 2016-03-18 | Carboplatin + Etoposide iv&po | 02 | null | 300026167 | OXALIPLATIN + MDG |
| 300004920 | 300003377 | 1.86 | 67.4 | Disease modification (D) | 2014-01-16 | 2014-01-29 | MITOMYCIN | N | N | 300026170 | TEMOZOLOMIDE + RT |
| 300004921 | 300003377 | 1.76 | 78.5 | Neo-adjuvant (N) | 2016-05-25 | 2016-06-22 | Cisplatin + Docetaxel | 01 | N | 300026170 | IMATINIB |
| 300004922 | 300003378 | null | 56 | null | null | 2015-11-09 | null | null | null | 300026174 | CAPECITABINE + CISPLATIN + RT |
| 300004923 | 300003379 | null | 66.6 | Palliative (P) | 2017-01-31 | 2017-01-31 | GEMCARBO | N | null | 300026182 | GEMCARBO |
| 300004924 | 300003379 | 1.82 | 53.7 | Palliative (P) | 2015-08-04 | 2015-08-14 | Oxaliplatin + Modified de Gramont | null | N | 300026182 | CAPECITABINE + GEMCITABINE |
| 300004925 | 300003380 | 1.8 | 0 | Neo-adjuvant (N) | 2014-02-04 | 2014-02-20 | AML 19 TRIAL | N | N | 300026189 | FLUOROURACIL + MITOMYCIN |
| 300004926 | 300003380 | 1.61 | 74 | Palliative (P) | 2016-07-14 | 2016-07-30 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | 300026189 | GEMCARBO |
| 300004927 | 300007518 | 1.75 | 81.8 | Adjuvant (A) | 2014-09-29 | 2014-09-29 | Trastuzumab Subcutaneous | 02 | N | 300026205 | EC |
| 300004928 | 300008002 | 1.83 | 94 | Curative (C) | 2013-10-03 | 2013-11-20 | CHOP R - 21 days | Y | Y | 300026226 | CARBO + FLUOROURACIL |
| 300004929 | 300008002 | 1.54 | 67 | Curative (C) | null | 2017-08-04 | FEC + TRASTUZUMAB | N | N | 300026226 | FLUOROURACIL |
| 300004930 | 300003381 | null | 56.4 | Palliative (P) | 2015-04-26 | 2015-05-18 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 300026234 | CETUXIMAB + CISPLATIN + FU |
| 300004931 | 300003382 | 1.6 | 46.9 | Palliative (P) | 2015-09-01 | 2015-09-02 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | 300026236 | TEMOZOLOMIDE + RT |